Cited by

• Selective inhibition of proteoglycan and hyaluronate synthesis in chondrocyte cultures by cyclofenil diphenol, a non-steroidal weak oestrogen.

  Mason RM, Lineham JD, Phillipson MA, Black CM. Mason RM, et al. Biochem J. 1984 Oct 15;223(2):401-12. doi: 10.1042/bj2230401. Biochem J. 1984. PMID: 6437390 Free PMC article.
• Altered procollagen mRNA expression during the progression of avian scleroderma.

  Ausserlechner MJ, Sgonc R, Dietrich H, Wick G. Ausserlechner MJ, et al. Mol Med. 1997 Oct;3(10):654-62. Mol Med. 1997. PMID: 9392002 Free PMC article.
• Decreased bradykinin binding sites in fibroblasts from progressive systemic scleroderma.

  Ozeki T, Osada K, Seishima M, Mori S, Nozawa Y. Ozeki T, et al. Arch Dermatol Res. 1994;286(3-4):133-6. doi: 10.1007/BF00374207. Arch Dermatol Res. 1994. PMID: 8002664
• Origin of the enhanced activity of lysosomal beta-galactosidase in serum and skin in progressive systemic sclerosis.

  Herrmann K, Schulze E, Haustein UF, Böhme HJ, Ziegler V. Herrmann K, et al. Arch Dermatol Res. 1987;279(5):299-302. doi: 10.1007/BF00431221. Arch Dermatol Res. 1987. PMID: 3115193
• Alterations in intracellular calcium transients of fibroblasts from progressive systemic sclerotic patients: a digital imaging microscopic study.

  Seishima M, Kudo Y, Nagao S, Mori S, Nozawa Y. Seishima M, et al. Arch Dermatol Res. 1991;283(2):96-9. doi: 10.1007/BF00371616. Arch Dermatol Res. 1991. PMID: 2069418